FIrst-Pass Reperfusion With the NeVa Stent-Retriever Trial

NCT04072367 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-04-27

No results posted yet for this study

Summary

This study is designed to compare the safety, performance and efficacy of blood clot (thrombus) removal in subjects presenting with acute ischemic stroke with the NeVa versus the Solitaire stent retrievers.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

NeVa Stent Retrievers

thrombus removal

DEVICE

Solitaire Stent Retrievers

thrombus removal

Sponsors & Collaborators

  • Vesalio

    lead INDUSTRY

Principal Investigators

  • Raul Gomes Nogueira, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2020-12-31
Completion
2020-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04072367 on ClinicalTrials.gov